GAETANI, LORENZO
GAETANI, LORENZO
Dipartimento di Medicina e Chirurgia
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes
2018 Gaetani, Lorenzo; Prosperini, Luca; Mancini, Andrea; Eusebi, Paolo; Cerri, Maria Chiara; Pozzilli, Carlo; Calabresi, Paolo; Sarchielli, Paola; Di Filippo, Massimiliano
A blood test for Alzheimer's disease: a step forward
2021 Parnetti, L.; Filippo, M. D.; Gaetani, L.
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis
2024 Zelante, T.; Paolicelli, G.; Fallarino, F.; Gargaro, M.; Vascelli, G.; De Zuani, M.; Fric, J.; Laznickova, P.; Kohoutkova, M. H.; Macchiarulo, A.; Dolciami, D.; Pieraccini, G.; Gaetani, L.; Scalisi, G.; Trevisan, C.; Frossi, B.; Pucillo, C.; De Luca, A.; Nunzi, E.; Spaccapelo, R.; Pariano, M.; Borghi, M.; Boscaro, F.; Romoli, R.; Mancini, A.; Gentili, L.; Renga, G.; Costantini, C.; Puccetti, M.; Giovagnoli, S.; Ricci, M.; Antonini, M.; Calabresi, P.; Puccetti, P.; Di Filippo, M.; Romani, L.
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation
2018 Gaetani, Lorenzo; Höglund, Kina; Parnetti, Lucilla; Pujol-Calderon, Fani; Becker, Bruno; Eusebi, Paolo; Sarchielli, Paola; Calabresi, Paolo; Di Filippo, Massimiliano; Zetterberg, Henrik; Blennow, Kaj
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers
2022 Barba, L.; Paolini Paoletti, F.; Bellomo, G.; Gaetani, L.; Halbgebauer, S.; Oeckl, P.; Otto, M.; Parnetti, L.
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease
2024 Gómez de San José, Nerea; Halbgebauer, Steffen; Steinacker, Petra; Anderl-Straub, Sarah; Abu-Rumeileh, Samir; Barba, Lorenzo; Oeckl, Patrick; Bellomo, Giovanni; Gaetani, Lorenzo; Toja, Andrea; Mravinacová, Sára; Bergström, Sofia; Månberg, Anna; Grassini, Alberto; Rainero, Innocenzo; Nilsson, Peter; Parnetti, Lucilla; Otto, Markus
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD
2023 Chipi, E; Bellomo, G; Salvadori, N; Montanucci, C; Gaetani, L; Paolini Paoletti, F; Parnetti, L
Author Response: NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use
2022 Parnetti, Lucilla; Gaetani, Lorenzo
Biomarker-Based Prediction of Parkinson Disease: Time for a Shift in Neurologists' Attitude Toward Neurodegenerative Diseases
2024 Parnetti, Lucilla; Gaetani, Lorenzo
Blood biomarkers may distinguish among dementia disorders
2022 Parnetti, Lucilla; Paolini Paoletti, Federico; Gaetani, Lorenzo
Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease
2020 Nuzzo, T.; Miroballo, M.; Casamassa, A.; Mancini, A.; Gaetani, L.; Nistico, R.; Eusebi, P.; Katane, M.; Homma, H.; Calabresi, P.; Errico, F.; Parnetti, L.; Usiello, A.
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis
2020 Gaetani, L.; Di Carlo, M.; Brachelente, G.; Valletta, F.; Eusebi, P.; Mancini, A.; Gentili, L.; Borrelli, A.; Calabresi, P.; Sarchielli, P.; Ferri, C.; Villa, A.; Di Filippo, M.
Cerebrospinal fluid interferon-γ and development of depression in multiple sclerosis
2025 Menculini, Giulia; Sperandei, Silvia; Gaetani, Lorenzo; Mancini, Andrea; Cinesi, Gianmarco; Di Sabatino, Elena; Bellingacci, Laura; Canonichesi, Jacopo; Guerrera, Gisella; Battistini, Luca; Tortorella, Alfonso; Parnetti, Lucilla; Borsellino, Giovanna; Di Filippo, Massimiliano
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease
2022 Barschke, Peggy; Abu-Rumeileh, Samir; Al Shweiki, M H D Rami; Barba, Lorenzo; Paolini Paoletti, Federico; Oeckl, Patrick; Steinacker, Petra; Halbgebauer, Steffen; Gaetani, Lorenzo; Lewerenz, Jan; Ludolph, Albert Christian; Landwehrmeyer, Georg Bernhard; Parnetti, Lucilla; Otto, Markus
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis
2019 Gaetani, L.; Eusebi, P.; Mancini, A.; Gentili, L.; Borrelli, A.; Parnetti, L.; Calabresi, P.; Sarchielli, P.; Blennow, K.; Zetterberg, H.; Di Filippo, M.
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis
2019 Gaetani, L.; Salvadori, N.; Lisetti, V.; Eusebi, P.; Mancini, A.; Gentili, L.; Borrelli, A.; Portaccio, E.; Sarchielli, P.; Blennow, K.; Zetterberg, H.; Parnetti, L.; Calabresi, P.; Di Filippo, M.
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease
2023 Barba, Lorenzo; Abu Rumeileh, Samir; Bellomo, Giovanni; Paolini Paoletti, Federico; Halbgebauer, Steffen; Oeckl, Patrick; Steinacker, Petra; Massa, Federico; Gaetani, Lorenzo; Parnetti, Lucilla; Otto, Markus
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease
2024 Barba, Lorenzo; Abu-Rumeileh, Samir; Barthel, Henryk; Massa, Federico; Foschi, Matteo; Bellomo, Giovanni; Gaetani, Lorenzo; Thal, Dietmar R; Parnetti, Lucilla; Otto, Markus
Clinical correlates of state and trait anxiety in multiple sclerosis
2022 Menculini, Giulia; Gentili, Lucia; Gaetani, Lorenzo; Mancini, Andrea; Sperandei, Silvia; Di Sabatino, Elena; Chipi, Elena; Salvadori, Nicola; Tortorella, Alfonso; Parnetti, Lucilla; Di Filippo, Massimiliano
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers
2020 Gaetani, Lorenzo; Salvadori, Nicola; Chipi, Elena; Gentili, Lucia; Borrelli, Angela; Parnetti, Lucilla; Di Filippo, Massimiliano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes | 2018 | Gaetani, Lorenzo; Prosperini, Luca; Mancini, Andrea; Eusebi, Paolo; Cerri, Maria Chiara; Pozzilli, Carlo; Calabresi, Paolo; Sarchielli, Paola; Di Filippo, Massimiliano | |
| A blood test for Alzheimer's disease: a step forward | 2021 | Parnetti, L.; Filippo, M. D.; Gaetani, L. | |
| A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis | 2024 | Zelante, T.; Paolicelli, G.; Fallarino, F.; Gargaro, M.; Vascelli, G.; De Zuani, M.; Fric, J.; Laznickova, P.; Kohoutkova, M. H.; Macchiarulo, A.; Dolciami, D.; Pieraccini, G.; Gaetani, L.; Scalisi, G.; Trevisan, C.; Frossi, B.; Pucillo, C.; De Luca, A.; Nunzi, E.; Spaccapelo, R.; Pariano, M.; Borghi, M.; Boscaro, F.; Romoli, R.; Mancini, A.; Gentili, L.; Renga, G.; Costantini, C.; Puccetti, M.; Giovagnoli, S.; Ricci, M.; Antonini, M.; Calabresi, P.; Puccetti, P.; Di Filippo, M.; Romani, L. | |
| A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation | 2018 | Gaetani, Lorenzo; Höglund, Kina; Parnetti, Lucilla; Pujol-Calderon, Fani; Becker, Bruno; Eusebi, Paolo; Sarchielli, Paola; Calabresi, Paolo; Di Filippo, Massimiliano; Zetterberg, Henrik; Blennow, Kaj | |
| Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers | 2022 | Barba, L.; Paolini Paoletti, F.; Bellomo, G.; Gaetani, L.; Halbgebauer, S.; Oeckl, P.; Otto, M.; Parnetti, L. | |
| Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease | 2024 | Gómez de San José, Nerea; Halbgebauer, Steffen; Steinacker, Petra; Anderl-Straub, Sarah; Abu-Rumeileh, Samir; Barba, Lorenzo; Oeckl, Patrick; Bellomo, Giovanni; Gaetani, Lorenzo; Toja, Andrea; Mravinacová, Sára; Bergström, Sofia; Månberg, Anna; Grassini, Alberto; Rainero, Innocenzo; Nilsson, Peter; Parnetti, Lucilla; Otto, Markus | |
| Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD | 2023 | Chipi, E; Bellomo, G; Salvadori, N; Montanucci, C; Gaetani, L; Paolini Paoletti, F; Parnetti, L | |
| Author Response: NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use | 2022 | Parnetti, Lucilla; Gaetani, Lorenzo | |
| Biomarker-Based Prediction of Parkinson Disease: Time for a Shift in Neurologists' Attitude Toward Neurodegenerative Diseases | 2024 | Parnetti, Lucilla; Gaetani, Lorenzo | |
| Blood biomarkers may distinguish among dementia disorders | 2022 | Parnetti, Lucilla; Paolini Paoletti, Federico; Gaetani, Lorenzo | |
| Cerebrospinal fluid and serum D-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease | 2020 | Nuzzo, T.; Miroballo, M.; Casamassa, A.; Mancini, A.; Gaetani, L.; Nistico, R.; Eusebi, P.; Katane, M.; Homma, H.; Calabresi, P.; Errico, F.; Parnetti, L.; Usiello, A. | |
| Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis | 2020 | Gaetani, L.; Di Carlo, M.; Brachelente, G.; Valletta, F.; Eusebi, P.; Mancini, A.; Gentili, L.; Borrelli, A.; Calabresi, P.; Sarchielli, P.; Ferri, C.; Villa, A.; Di Filippo, M. | |
| Cerebrospinal fluid interferon-γ and development of depression in multiple sclerosis | 2025 | Menculini, Giulia; Sperandei, Silvia; Gaetani, Lorenzo; Mancini, Andrea; Cinesi, Gianmarco; Di Sabatino, Elena; Bellingacci, Laura; Canonichesi, Jacopo; Guerrera, Gisella; Battistini, Luca; Tortorella, Alfonso; Parnetti, Lucilla; Borsellino, Giovanna; Di Filippo, Massimiliano | |
| Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease | 2022 | Barschke, Peggy; Abu-Rumeileh, Samir; Al Shweiki, M H D Rami; Barba, Lorenzo; Paolini Paoletti, Federico; Oeckl, Patrick; Steinacker, Petra; Halbgebauer, Steffen; Gaetani, Lorenzo; Lewerenz, Jan; Ludolph, Albert Christian; Landwehrmeyer, Georg Bernhard; Parnetti, Lucilla; Otto, Markus | |
| Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis | 2019 | Gaetani, L.; Eusebi, P.; Mancini, A.; Gentili, L.; Borrelli, A.; Parnetti, L.; Calabresi, P.; Sarchielli, P.; Blennow, K.; Zetterberg, H.; Di Filippo, M. | |
| Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis | 2019 | Gaetani, L.; Salvadori, N.; Lisetti, V.; Eusebi, P.; Mancini, A.; Gentili, L.; Borrelli, A.; Portaccio, E.; Sarchielli, P.; Blennow, K.; Zetterberg, H.; Parnetti, L.; Calabresi, P.; Di Filippo, M. | |
| Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease | 2023 | Barba, Lorenzo; Abu Rumeileh, Samir; Bellomo, Giovanni; Paolini Paoletti, Federico; Halbgebauer, Steffen; Oeckl, Patrick; Steinacker, Petra; Massa, Federico; Gaetani, Lorenzo; Parnetti, Lucilla; Otto, Markus | |
| Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease | 2024 | Barba, Lorenzo; Abu-Rumeileh, Samir; Barthel, Henryk; Massa, Federico; Foschi, Matteo; Bellomo, Giovanni; Gaetani, Lorenzo; Thal, Dietmar R; Parnetti, Lucilla; Otto, Markus | |
| Clinical correlates of state and trait anxiety in multiple sclerosis | 2022 | Menculini, Giulia; Gentili, Lucia; Gaetani, Lorenzo; Mancini, Andrea; Sperandei, Silvia; Di Sabatino, Elena; Chipi, Elena; Salvadori, Nicola; Tortorella, Alfonso; Parnetti, Lucilla; Di Filippo, Massimiliano | |
| Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers | 2020 | Gaetani, Lorenzo; Salvadori, Nicola; Chipi, Elena; Gentili, Lucia; Borrelli, Angela; Parnetti, Lucilla; Di Filippo, Massimiliano |